Back
Sonoco Products 10K Form
Sell
40
SON
Sonoco Products
Last Price:
$45.12
Seasonality Move:
0.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | SON/Sonoco Products Quarterly |
2023-08-02 | 10Q | SON/Sonoco Products Quarterly |
2023-05-03 | 10Q | SON/Sonoco Products Quarterly |
2022-11-02 | 10Q | SON/Sonoco Products Quarterly |
2022-08-02 | 10Q | SON/Sonoco Products Quarterly |
2022-05-03 | 10Q | SON/Sonoco Products Quarterly |
Receive SON News And Ratings
See the #1 stock for the next 7 days that we like better than SON
SON Financial Statistics
Sales & Book Value
Annual Sales: | $5.3B |
---|---|
Cash Flow: | $-300.8M |
Price / Cash Flow: | 74.58 |
Annual Sales: | $24.82 |
Price / Book: | 1.82 |
Profitability
EPS (TTM): | 1.54000 |
---|---|
Net Income (TTM): | $153.2M |
Gross Margin: | $1.1B |
Return on Equity: | 6.33% |
Return on Assets: | 1.58% |
Sonoco Products Earnings Forecast
Key Sonoco Products Financial Ratios
-
The Gross Profit Margin over the past 41 years for SON is 21.47%.
-
The Selling, General & Administrative Expenses for SON have been equal to 13.64% of Gross Profit Margin.
-
The Research & Development expenses have been 0.42% of Revenue.
-
The Interest Expense is 105.29% of Operating Income.
-
The Net Earning history of SON is 3.09% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 27 years.
Sonoco Products Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | SON |
CUSIP: | 835495 |
Website: | sonoco.com |
Debt
Debt-to-Equity Ratio: | 2.91 |
---|---|
Current Ratio: | 0.8 |
Quick Ratio: | 0.34 |
Price-to-Earnings
Trailing P/E Ratio: | 27.34 |
---|---|
Forward P/E Ratio: | 7 |
SON Technical Analysis vs Fundamental Analysis
Sell
40
Sonoco Products (SON)
is a Sell
Is Sonoco Products a Buy or a Sell?
-
Sonoco Products stock is rated a SellThe current Sonoco Products [SON] share price is $45.11. The Score for SON is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.